# Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density

> **NCT03264651** · PHASE1 · COMPLETED · sponsor: **Havah Therapeutics Pty Ltd** · enrollment: 9 (actual)

## Conditions studied

- Mammographic Density

## Interventions

- **DRUG:** enobosarm

## Key facts

- **NCT ID:** NCT03264651
- **Lead sponsor:** Havah Therapeutics Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2018-03-21
- **Final completion:** 2018-03-21
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2018-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03264651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03264651, "Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03264651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*